KingMed Diagnostics

KingMed Diagnostics (Stock Code: 603882) is headquartered in Guangzhou and is a market-leading enterprise in China's third-party medical testing industry. With 49 chain central laboratories nationwide, nearly 700 co-built laboratories, and a nationwide remote pathology collaboration network, KingMed Diagnostics offers over 4,000 medical testing and pathological diagnosis items, providing 'full life cycle, full disease coverage, full diagnosis and treatment management' medical testing and pathological diagnosis services to more than 23,000 medical institutions across the country. Its service network covers areas inhabited by over 90% of the national population, extending high-quality medical testing services to the township and community levels. KingMed Diagnostics has 1,397 R&D personnel, more than 280 renowned experts from home and abroad, and has established the KingMed Diagnostics Academic Committee, chaired by Academician Zhong Nanshan, with 9 academicians including Chen Runsheng, Chen Yeguang, Huang Hefeng, Hou Fanfan, Li Xiaokun, Tan Weihong, Xie Xiaoliang, Zhang Xue, and Zeng Yitao serving as advisors, totaling 57 top experts from domestic and international testing, pathology, clinical and other industries. KingMed Diagnostics has 84 categories of medical testing technology platforms across 11 major disciplines. (For details, please visit the company website: * )